Jump to navigation
Jump to footer
CR Report 2005
Summary and highlights
CEO/Chairman statement
About this report
Managing CR
Access to medicines
Research
Ethical conduct
Employees
Human rights
Environment
Community investment
Data summary
Case studies
PDF downloads
Report index
Site map
GRI index
Feedback
Home
Responsibility
CR Report 2005
Report index
Site map
Site map
CR Report 2005
Summary and highlights
CEO/Chairman statement
About this report
Managing CR
Why CR is important to GSK
Our CR principles
Stakeholder engagement
Stakeholder feedback
Stakeholder feedback
How we are responding
How we are responding
Government and external affairs
Membership of trade associations
Political donations
US lobbying expenditure
Policy positions
Patient advocacy
Principles for working with patient groups
Access to medicines
Developing world
Research and development
Preferential pricing
Eligibility for not-for-profit prices
Voluntary licensing and partnerships
Major public health initiatives
Developed world
Research
Animal research
Conduct of clinical trials
Training and auditing for clinical trials
Clinical trial information and results
Ethical conduct
Code of conduct
Marketing ethics
Marketing codes of practice
Consumer advertising
Training and awareness
Monitoring and compliance
Employees
Employee surveys
Diversity
Employee development and talent management
Internal communication
Health and safety
How we manage health and safety
Injury and illness (rates and causes)
Serious incidents and fatalities
Employee health
Safety programmes
Human rights
Employees
Suppliers
Human rights clause
Environment
Verification
Environmental management
Plan for excellence
Audits and certification
Stakeholder engagement
Training and awareness
EHS excellence award
Progress towards targets
Materials efficiency
Product stewardship
Product design
Pharmaceuticals in the environment
Metered Dose Inhalers
Energy and global warming potential
Energy consumption
Transport
Water
Water use
Wastewater
Waste
Hazardous waste
Non-hazardous waste
Recycling
Non-routine waste
Ozone depletion
ODS in manufacturing
ODS in ancillary equipment
Volatile organic compounds
Biodiversity
Suppliers
Community investment
Value of community investment
Humanitarian relief
Community partnerships
Supporting education
Employee involvement
Data summary
Case studies
PDF downloads
Report index
Site map
GRI index
Economic indicators
Environmental indicators
Social indicators
Feedback
Back to top